Codexis

company

About

Codexis is a biosciences company applying synthetic chemistry technologies to create improved versions of small molecule therapeutics.

Details

Last Funding Type
Series D
Last Funding Money Raised
$37M
Industries
Biotechnology,Chemical,Sustainability
Founded date
Jan 1, 2002
Number Of Employee
51 - 100
Operating Status
Active
Stock Symbol
nasdaq:CDXS

Codexis, Inc. is an industrial biotechnology company that specializes in engineers enzymes for pharmaceutical and chemical production through biocatalysis. Codexis’ technologies enable scale-up and implementation of biocatalytic solutions to optimize process development, from research to manufacturing. There are currently over 50 pharmaceutical firms using Codexis’ technology, products and services in their manufacturing process development.
Codexis creates its products by applying its CodeEvolver® directed evolution technology platform, which introduces genetic mutations into microorganisms.
Codexis, Inc. began operations as an independent company in 2002, and became a publicly traded company in 2009. They are located in Redwood City, CA USA

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$240M
Codexis has raised a total of $240M in funding over 2 rounds. Their latest funding was raised on Dec 2, 2020 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 2, 2020 Post-IPO Equity $75M Detail
Jun 20, 2019 Post-IPO Equity $50M 1 Casdin Capital Detail
Apr 30, 2010 IPO $78M Detail
Aug 14, 2006 Series D $37M 5 EDBI Detail

Investments

Number of Investments
Number of Lead Investments
3
1
Codexis has made 3 investments. Their most recent investment was on Mar 29, 2022, when seqWell raised $7M.
Date Company Name
Round Money Raised Industry Lead Investor
Mar 29, 2022 seqWell
Series C $7M Biotechnology Yes
Series B $25.80M Biotechnology
Series A $11.80M Biotechnology

Investors

Number of Lead Investors
Number of Investors
2
6
Codexis is funded by 6 investors. Casdin Capital and EDBI are the most recent investors.
Investor Name Lead Investor Funding Round
Casdin Capital Yes Post-IPO Equity
EDBI Yes Series D
Chevron Technology Ventures Series D
CMEA Capital Series D
Maxygen Series D
Pequot Capital Series D

Employee Profiles

Number of Employee Profiles
10
Codexis has 10 current employee profiles, including Executive Stephen Dilly
Executive
Executive
Board member
Employee
Executive